María Teresa Vargas

Author

María Teresa Vargas

Hospital Universitario Virgen Macarena ORCID

Also Known As

M. T. VARGAS, M. T. Vargas, M. Teresa Vargas, M. Vargas, M.T. Vargas, MT Vargas, Maria T. Vargas, Maria Teresa Vargas, Maria Vargas, María T. Vargas

Publications

985

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Virgen Macarena Instituto de Biomedicina de Sevilla Universidad de Sevilla Instituto de Salud Carlos III Fundación PROINPA

About

María Teresa Vargas is an author at Hospital Universitario Virgen Macarena specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	93
2	Cell Biology	2	2	75
3	Business	1	1	312
4	Engineering	1	1	312
5	Health Sciences	1	1	18

María Teresa Vargas

Publications

900

Citations

H-Index

Page 1

	Year	Citations
Selling two environmental services: In-kind payments for bird habitat and watershed protection in Los Negros, Bolivia Nigel Asquith, María Teresa Vargas, Sven Wunder Ecological Economics EconomicsBird HabitatEngineeringNatural Resource ValuationEnvironmental Services	2008	312
Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection Nerea Matamala, María Teresa Vargas, Ricardo González‐Cámpora, Clinical Chemistry	2015	219
Antithyroid Microsomal Autoantibodies and HLA-DR5 Are Associated With Postpartum Thyroid Dysfunction: Evidence Supporting an Autoimmune Pathogenesis* María Teresa Vargas, Rosario Brioñes‐Urbina, D Gladman, The Journal of Clinical Endocrinology & Metabolism	1988	106
Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada Paul G. Walfish, Joseph Meyerson, John Provias, Journal of Endocrinological Investigation Post-partum Thyroid DysfunctionThyroid DiseaseThyroid DisordersThyroid HormoneEndocrine Disease	1992	98
MicroRNA deregulation in triple negative breast cancer reveals a role of miR-498 in regulating <i>BRCA1</i> expression Nerea Matamala, María Teresa Vargas, Ricardo González‐Cámpora, Oncotarget Breast OncologyMedicineMicrorna DeregulationCancer Cell BiologyBreast Cancer	2016	59
Application of fluorescence<i>in situ</i>hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens A. Abásolo, María Teresa Vargas, J.J. Ríos-Martín, Clinical and Experimental Dermatology	2012	20
<i>ASXL1</i> mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype Concepción Prats‐Martín, Sergio Burillo‐Sanz, Rosario M. Morales‐Camacho, Cancer Medicine	2020	20
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does −7/7q− detection by FISH have prognostic value? Vera Ademà, Jesús María Hernández‐Rivas, María Abáigar, Leukemia Research CytogeneticsFish 7QGeneticsMds PatientsHematology	2013	18
Cytogenetic, fluorescence in situ hybridization, and immunohistochemistry studies in a malignant pleural solitary fibrous tumor Francisco Javier Torres-Olivera, María Teresa Vargas, Francisco Javier Torres-Gómez, Cancer Genetics and Cytogenetics Tumoral PathologySurgical PathologyPathologyImmunohistochemistry StudiesPleural Disease	2009	16
<i><scp>NUP</scp>98–<scp>HOXA</scp>9</i> bearing therapy‐related myeloid neoplasm involves myeloid‐committed cell and induces <i><scp>HOXA</scp>5</i>,<i><scp>EVI</scp>1, <scp>FLT</scp>3,</i> and <i><scp>MEIS</scp>1</i> expression Sergio Burillo‐Sanz, Rosario M. Morales‐Camacho, Teresa Caballero‐Velázquez, International Journal of Laboratory Hematology	2015	12

Page 1